Androgen circle of polycystic ovary syndrome

被引:94
作者
Homburg, Roy [1 ,2 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, Reprod Med Div, NL-1007 MB Amsterdam, Netherlands
[2] Barzilai Govt Hosp, Ashqelon, Israel
关键词
androgens; polycystic ovary syndrome; ovary; anovulation; ANTI-MULLERIAN HORMONE; CONGENITAL ADRENAL-HYPERPLASIA; FEMALE RHESUS-MONKEYS; OBSTRUCTIVE SLEEP-APNEA; INSULIN-RESISTANCE; METABOLIC SYNDROME; YOUNG-WOMEN; TESTOSTERONE TREATMENT; FOLLICLE DEVELOPMENT; ANOVULATORY WOMEN;
D O I
10.1093/humrep/dep049
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Although the aetiology of polycystic ovary syndrome (PCOS) is still not known and the search for causative genes is proving elusive, it is generally agreed that hyperandrogenism is at the heart of the syndrome. Here, it is proposed that excess androgens are the root cause of PCOS starting from their influence on the female fetus in programming gene expression, producing the characteristic signs and symptoms which are then exacerbated by a propagation of excess ovarian androgen production from multiple small follicles, anovulation and insulin resistance in the reproductive life-span, thus setting up a vicious perpetual circle of androgen excess. This opinion paper, rather than being a full-scale review, is intentionally biased in support of this hypothesis that androgen excess is the 'root of all evil' in PCOS; in the hope that its acceptance could lead to more direct treatment of the syndrome in all its facets rather than the symptomatic treatment of side effects of androgen excess that we are addressing today.
引用
收藏
页码:1548 / 1555
页数:8
相关论文
共 81 条
  • [1] Endocrine antecedents of polycystic ovary syndrome in fetal and infant prenatally androgenized female rhesus monkeys
    Abbott, David H.
    Barnett, Deborah K.
    Levine, Jon E.
    Padmanabhan, Vasantha
    Dumesic, Daniel A.
    Jacoris, Steve
    Tarantal, Alice F.
    [J]. BIOLOGY OF REPRODUCTION, 2008, 79 (01) : 154 - 163
  • [2] Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?
    Abbott, DH
    Barnett, DK
    Bruns, CM
    Dumesic, DA
    [J]. HUMAN REPRODUCTION UPDATE, 2005, 11 (04) : 357 - 374
  • [3] Developmental origin of polycystic ovary syndrome - a hypothesis
    Abbott, DH
    Dumesic, DA
    Franks, S
    [J]. JOURNAL OF ENDOCRINOLOGY, 2002, 174 (01) : 1 - 5
  • [4] Abbott DH, 1997, ANDROGEN EXCESS DISORDERS IN WOMEN, P369
  • [5] Insights into the development of polycystic ovary syndrome (PCOS) from studies of prenatally androgenized female rhesus monkeys
    Abbott, DH
    Dumesic, DA
    Eisner, JR
    Colman, RJ
    Kemnitz, JW
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1998, 9 (02) : 62 - 67
  • [6] Abbott DH, 2009, EXPERT REV OBSTET GY, V4, P1
  • [7] The regulation of HSL and LPL expression by DHT and flutamide in human subcutaneous adipose tissue
    Anderson, LA
    McTernan, PG
    Harte, AL
    Barnett, AH
    Kumar, S
    [J]. DIABETES OBESITY & METABOLISM, 2002, 4 (03) : 209 - 213
  • [8] Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome
    Apridonidze, T
    Essah, PA
    Iuorno, MJ
    Nestler, JE
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04) : 1929 - 1935
  • [9] Metformin directly inhibits androgen production in human thecal cells
    Attia, GR
    Rainey, WE
    Carr, BR
    [J]. FERTILITY AND STERILITY, 2001, 76 (03) : 517 - 524
  • [10] OVARIAN HYPERANDROGYNISM AS A RESULT OF CONGENITAL ADRENAL VIRILIZING DISORDERS - EVIDENCE FOR PERINATAL MASCULINIZATION OF NEUROENDOCRINE FUNCTION IN WOMEN
    BARNES, RB
    ROSENFIELD, RL
    EHRMANN, DA
    CARA, JF
    CUTTLER, L
    LEVITSKY, LL
    ROSENTHAL, IM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (05) : 1328 - 1333